A fluorometric assay for total diamines in human urine using human placental diamine oxidase. 1981

T Matsumoto, and O Suzuki, and Y Katsumata, and M Oya, and Y Nimura, and M Akita, and T Hattori

The detailed procedure for a new fluorometric assay for total diamines in human urine is described. The diamines were purified from the urine by cation-exchange chromatography and incubated with human placental diamine oxidase. Hydrogen peroxide formed in the diamine oxidase reaction was measured fluorometrically by converting homovanillic acid to a highly fluorescent compound in the presence of peroxidase. Because of its simplicity and high sensitivity, our present method seems useful for routine clinical investigation. The data obtained from normal subjects and patients suffering from various forms of cancer are also presented.

UI MeSH Term Description Entries
D008722 Methods A series of steps taken in order to conduct research. Techniques,Methodological Studies,Methodological Study,Procedures,Studies, Methodological,Study, Methodological,Method,Procedure,Technique
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D010920 Placenta A highly vascularized mammalian fetal-maternal organ and major site of transport of oxygen, nutrients, and fetal waste products. It includes a fetal portion (CHORIONIC VILLI) derived from TROPHOBLASTS and a maternal portion (DECIDUA) derived from the uterine ENDOMETRIUM. The placenta produces an array of steroid, protein and peptide hormones (PLACENTAL HORMONES). Placentoma, Normal,Placentome,Placentas,Placentomes
D011247 Pregnancy The status during which female mammals carry their developing young (EMBRYOS or FETUSES) in utero before birth, beginning from FERTILIZATION to BIRTH. Gestation,Pregnancies
D011700 Putrescine A toxic diamine formed by putrefaction from the decarboxylation of arginine and ornithine. 1,4-Butanediamine,1,4-Diaminobutane,Tetramethylenediamine,1,4 Butanediamine,1,4 Diaminobutane
D002103 Cadaverine A foul-smelling diamine formed by bacterial DECARBOXYLATION of LYSINE. It is also an intermediate secondary metabolite in lysine-derived alkaloid biosynthetic pathways (e.g., QUINOLIZIDINES and LYCOPODIUM). 1,5-Pentanediamine,BioDex 1,Pentamethylenediamine,1,5 Pentanediamine
D002852 Chromatography, Ion Exchange Separation technique in which the stationary phase consists of ion exchange resins. The resins contain loosely held small ions that easily exchange places with other small ions of like charge present in solutions washed over the resins. Chromatography, Ion-Exchange,Ion-Exchange Chromatography,Chromatographies, Ion Exchange,Chromatographies, Ion-Exchange,Ion Exchange Chromatographies,Ion Exchange Chromatography,Ion-Exchange Chromatographies
D003959 Diamines Organic chemicals which have two amino groups in an aliphatic chain. Diamine
D005260 Female Females
D006631 Amine Oxidase (Copper-Containing) A group of enzymes including those oxidizing primary monoamines, diamines, and histamine. They are copper proteins, and, as their action depends on a carbonyl group, they are sensitive to inhibition by semicarbazide. Diamine Oxidase,Histaminase,Amine Oxidase, Copper-Containing,Copper Amine Oxidase,Diaminobenzidine Oxidase,Semicarbazide-Sensitive Amine Oxidase,Xylylene Diamine Oxidase,Amine Oxidase, Copper,Amine Oxidase, Copper Containing,Amine Oxidase, Semicarbazide-Sensitive,Copper-Containing Amine Oxidase,Diamine Oxidase, Xylylene,Oxidase, Copper Amine,Oxidase, Copper-Containing Amine,Oxidase, Diamine,Oxidase, Diaminobenzidine,Oxidase, Semicarbazide-Sensitive Amine,Oxidase, Xylylene Diamine,Semicarbazide Sensitive Amine Oxidase

Related Publications

T Matsumoto, and O Suzuki, and Y Katsumata, and M Oya, and Y Nimura, and M Akita, and T Hattori
August 1977, Clinica chimica acta; international journal of clinical chemistry,
T Matsumoto, and O Suzuki, and Y Katsumata, and M Oya, and Y Nimura, and M Akita, and T Hattori
April 2002, Inflammation research : official journal of the European Histamine Research Society ... [et al.],
T Matsumoto, and O Suzuki, and Y Katsumata, and M Oya, and Y Nimura, and M Akita, and T Hattori
May 1977, Chemical & pharmaceutical bulletin,
T Matsumoto, and O Suzuki, and Y Katsumata, and M Oya, and Y Nimura, and M Akita, and T Hattori
July 1962, Clinica chimica acta; international journal of clinical chemistry,
T Matsumoto, and O Suzuki, and Y Katsumata, and M Oya, and Y Nimura, and M Akita, and T Hattori
December 1967, Analytical biochemistry,
T Matsumoto, and O Suzuki, and Y Katsumata, and M Oya, and Y Nimura, and M Akita, and T Hattori
April 1969, Analytical biochemistry,
T Matsumoto, and O Suzuki, and Y Katsumata, and M Oya, and Y Nimura, and M Akita, and T Hattori
December 1979, Journal of clinical chemistry and clinical biochemistry. Zeitschrift fur klinische Chemie und klinische Biochemie,
T Matsumoto, and O Suzuki, and Y Katsumata, and M Oya, and Y Nimura, and M Akita, and T Hattori
December 1990, Clinical chemistry,
T Matsumoto, and O Suzuki, and Y Katsumata, and M Oya, and Y Nimura, and M Akita, and T Hattori
November 1973, Analytical biochemistry,
T Matsumoto, and O Suzuki, and Y Katsumata, and M Oya, and Y Nimura, and M Akita, and T Hattori
January 1988, Physiological chemistry and physics and medical NMR,
Copied contents to your clipboard!